Fri, Nov 06, 2020
CGSCIMB says they believe the domestic business’s strong recovery in growth should ensure healthy cash flows and better RocE. They initiate coverage on the Pharma sector with Overweight rating; add rating on Dr Reddy’s Labs, Cadila Healthcare, Alkem Labs, Cipla, IPCA Labs, Natco Pharma, Ajanta Pharma, Indoco Remedies and Hold rating on Alembic Pharma, Torrent Pharma.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
